CLINICAL EVALUATION OF QUINETHAZONE-RESERPINE COMBINATION IN HYPERTENSION.
D000959:Antihypertensive Agents; D035843:Biomedical Research; D002180:Candidiasis, Oral; D003920:Diabetes Mellitus; D004232:Diuretics; D004358:Drug Therapy; D006073:Gout; D006261:Headache; D006973:Hypertension; D007022:Hypotension; D007024:Hypotension, Orthostatic; D011141:Polyuria; D011799:Quinazolines; D012110:Reserpine; D013449:Sulfonamides; D014116:Toxicology; D014987:Xerostomia
D000959:Antihypertensive Agents; D004232:Diuretics; D011799:Quinazolines; D013449:Sulfonamides; C050700:quinethazone; D012110:Reserpine
ANTIHYPERTENSIVE AGENTS; CLINICAL RESEARCH; DIABETES MELLITUS; DIURETICS; DRUG THERAPY; GOUT; HEADACHE; HYPERTENSION; HYPOTENSION, ORTHOSTATIC; MONILIASIS, ORAL; POLYURIA; QUINETHAZONE; RESERPINE; TOXICOLOGIC REPORT; XEROSTOMIA